Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Sunrest Lifescience Ltd

Pharmaceuticals & Biotechnology | Small Cap

Sunrest Lifescience Ltd Health Insights
Health Score : 4.17Health Score : 4.17

Sunrest Lifescience Ltd demonstrates a mixed financial performance. The company shows strengths in profitability, driven by strong gross, operating, and net profit margins. Its coverage ratios are adequate, particularly regarding interest obligations. However, the company faces challenges in liquidity, growth, and efficiency, indicating potential difficulties in meeting short-term obligations and leveraging assets effectively. Financial ratios are also weak, suggesting limited earnings and book value per share. While the company's profitability and coverage offer some stability, addressing the weaknesses in liquidity, growth, efficiency, and financial metrics is crucial for sustained financial health and future success. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further impact the company's performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Sunrest Lifescience Ltd Health Insights
Health Score : 4.17Health Score : 4.17

Sunrest Lifescience Ltd demonstrates a mixed financial performance. The company shows strengths in profitability, driven by strong gross, operating, and net profit margins. Its coverage ratios are adequate, particularly regarding interest obligations. However, the company faces challenges in liquidity, growth, and efficiency, indicating potential difficulties in meeting short-term obligations and leveraging assets effectively. Financial ratios are also weak, suggesting limited earnings and book value per share. While the company's profitability and coverage offer some stability, addressing the weaknesses in liquidity, growth, efficiency, and financial metrics is crucial for sustained financial health and future success. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further impact the company's performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Highly Undervalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Highly Undervalued

P/E RATIO (TTM)

9.42

Highly Undervalued

Industry Median

28.62

Highly Undervalued
Undervalued

Small Cap Median

27.17

Undervalued

P/E RATIO

7.06

P/B RATIO

1.42

Undervalued

Industry Median

3.17

Undervalued
Undervalued

Small Cap Median

2.62

Undervalued

P/S RATIO

0.39

Highly Undervalued

Industry Median

3.42

Highly Undervalued
Highly Undervalued

Small Cap Median

2.55

Highly Undervalued

Others

Highly Undervalued

PEG RATIO

0.02

Highly Undervalued
Highly Undervalued

EV/EBITDA RATIO

2.88

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹33.9 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 2.00

The company's growth ratios are weak, indicating limited expansion in revenue, operating profit, earnings per share, assets, and net income. This raises concerns about the company's ability to capitalize on market opportunities and sustain long-term growth. Without significant growth, the company may struggle to attract investors and maintain its competitive position in the market. Strategic initiatives are needed to stimulate growth across various financial metrics.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
PoorAsset Growth RatePoor
PoorNet Income Growth RatePoor
Growth RatiosMar 2025Mar 2026
Revenue Growth Rate112
Operating Profit Growth Rate236.96
Earnings Per Share (EPS) Growth105.13
Asset Growth Rate21.76
Net Income Growth Rate296.04
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 3.60

The company's financial ratios indicate mixed performance. While capital expenditures are well-managed, the adjusted and cash earnings per share, book value per share, and dividend per share are low. Managing capital expenditures helps control costs, but the low earnings and book value per share raise concerns about profitability and shareholder value. Improving these metrics is essential for enhancing overall financial health and attracting investors.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
PoorCash Earnings Per Share (Cash EPS)Poor
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)4.727.91
Cash Earnings Per Share (Cash EPS)4.9321.37
Book Value Per Share37.9347.51
Dividend Per Share (DPS)00
Capital Expenditures (CapEx)1.22.7
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 5.60

The company's profitability ratios are strong, driven by high gross, operating, and net profit margins. These favorable margins indicate efficient cost management and effective pricing strategies. Strong profitability is a key strength, providing the company with financial stability and the ability to reinvest in growth opportunities. However, returns on capital employed, equity and assets are low.

ExcellentGross Profit MarginExcellent
PoorReturn on Capital Employed (ROCE)Poor
PoorReturn on Equity (ROE)Poor
PoorReturn on Assets (ROA)Poor
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2025Mar 2026
Gross Profit Margin8.7712.73
Return on Capital Employed (ROCE)13.2928.55
Return on Equity (ROE)12.3939.16
Return on Assets (ROA)5.1714.3
Operating Margin9.0714.41
Net Margin6.0511.29
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The company's efficiency in asset utilization is mixed. While days sales in inventory and receivable days are favorable, indicating efficient inventory and receivables management, the fixed asset and capital turnover ratios are weak, suggesting underutilization of assets to generate revenue. Efficient inventory and receivables management helps optimize working capital, while improving asset turnover is essential for enhancing overall operational efficiency and profitability.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2025Mar 2026
Fixed Asset Turnover Ratio7.668.28
Inventory Turnover Ratio3.174.63
Receivables Turnover Ratio0.922.06
Days Sales in Inventory Ratio115.1478.83
Receivable Days397.34177.18
Capital Turnover Ratio1.522.19
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 5.60

The company shows a good capacity to cover its interest obligations, but dividend coverage is weak. The favorable interest coverage ratio offers financial stability, ensuring the company can comfortably meet its debt obligations. However, the limited equity dividend coverage raises concerns about the ability to consistently reward shareholders. Balancing debt obligations and shareholder returns is crucial for maintaining investor confidence and financial health.

GoodInterest Coverage RatioGood
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2025Mar 2026
Interest Coverage Ratio9.458.12
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 8.00

The company's solvency position presents a mixed picture. While debt ratios are favorable, suggesting lower financial leverage, the equity ratio is weak, indicating a smaller proportion of assets financed by equity. A lower debt burden provides financial flexibility, but a thin equity base may increase vulnerability to market fluctuations and economic downturns. Balancing debt and equity is crucial for long-term financial stability.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
PoorEquity RatioPoor
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2025Mar 2026
Debt Ratio0.260.37
Debt to Equity Ratio0.350.59
Equity Ratio0.740.63
Debt To Asset Ratio0.10.17
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is weak, indicating potential difficulties in meeting its short-term obligations. The low current, quick, and cash ratios suggest insufficient liquid assets to cover current liabilities. While a conservative approach to liquidity can sometimes be justified, the consistent lack of liquid assets raises concerns about the company's ability to handle unexpected expenses or take advantage of immediate investment opportunities. This may affect its operational flexibility and increase financial risk.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2025Mar 2026
Current Ratio1.481.61
Quick Ratio1.221.17
Cash Ratio0.050.07
Operating Cash Flow Ratio0.080
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 2 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Sunrest Lifescience Ltd4.177.06Highly Undervalued10.213.608.00
2Ortin Global Ltd3.45-19.80Neutral-0.72-0.91-0.74
Management Assessment Summary
OrangeBalanced Management

The management effectiveness of Sunrest Lifescience Ltd is mixed. While the company demonstrates a reasonable Operating Profit Margin (OPM) of 9.07%, indicating operational efficiency, there are concerns regarding growth and returns due to the absence of compounded sales growth and profit growth data. The ROCE is 6.34%, and the ROE is 2.61%, both quite low. The lack of dividend payouts and recent sales and profit data necessitates a cautious assessment.

Category Metric Value Assessment
PROS Operating Profit Margin 9.07% Indicates operational efficiency
CONS Return on Capital Employed 6.34% Low return on capital employed
Return on Equity 2.61% Low return on equity
AverageFinancial Performance & GrowthAverage
PoorCapital Efficiency & ReturnsPoor
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Sunrest Lifescience Ltd indicates moderate risk. There are limited data points to comprehensively evaluate several risk factors. The absence of information on off-balance sheet exposures and contingent liabilities prevents a complete assessment of potential financial vulnerabilities. The lack of segment performance volatility data makes it difficult to assess the consistency of revenue streams. The absence of foreign exchange or interest rate exposure data and regulatory compliance cost trends further limits the risk assessment. Given these limitations, a cautious approach is warranted.

PoorOff-balance sheet exposure quantificationPoor
PoorContingent liability evaluationPoor
PoorSegment performance volatilityPoor
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1033.39Bullish
  3. SMA 2033.32Bullish
  4. SMA 5034.66Bearish
  5. EMA 1033.53Bullish
  6. EMA 2033.60Bullish
  7. EMA 5034.43Bearish
  8. DEMA 1033.69Bullish
  9. DEMA 2033.17Bullish
  10. DEMA 5033.15Bullish
  11. TEMA 1034.00Bearish
  12. TEMA 2033.47Bullish
  13. TEMA 5032.88Bullish
  14. MACD-0.25Bullish
  15. ADX28.70Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.45Neutral
  3. CCI75.90Neutral
  4. ROC 92.42Bullish
  5. ROC 141.19Bullish
  6. ROC 25-0.29Bearish
  7. Stoch K97.22Overbought
  8. Stoch D90.94Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper34.58Neutral
  3. BB Middle33.32Neutral
  4. BB Lower32.07Neutral
  5. ATR0.20Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI37.95Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1033.18Bullish
  3. SMA 2033.83Bullish
  4. SMA 5035.63Bearish
  5. EMA 1033.57Bullish
  6. EMA 2033.95Bearish
  7. EMA 5035.16Bearish
  8. DEMA 1033.42Bullish
  9. DEMA 2033.08Bullish
  10. DEMA 5033.43Bullish
  11. TEMA 1033.76Bullish
  12. TEMA 2033.10Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.60Bullish
  15. ADX22.12Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI45.94Neutral
  3. CCI3.80Neutral
  4. ROC 91.19Bullish
  5. ROC 14-0.29Bearish
  6. ROC 25-3.14Bearish
  7. Stoch K94.59Overbought
  8. Stoch D76.98Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper35.82Neutral
  3. BB Middle33.83Neutral
  4. BB Lower31.84Neutral
  5. ATR0.36Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI42.03Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1033.56Bullish
  3. SMA 2034.71Bearish
  4. SMA 5036.09Bearish
  5. EMA 1033.86Bullish
  6. EMA 2034.60Bearish
  7. EMA 5036.60Bearish
  8. DEMA 1033.20Bullish
  9. DEMA 2033.29Bullish
  10. DEMA 50N/AN/A
  11. TEMA 1033.33Bullish
  12. TEMA 2033.08Bullish
  13. TEMA 50N/AN/A
  14. MACD-1.00Bearish
  15. ADX19.42Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI43.97Neutral
  3. CCI-48.53Neutral
  4. ROC 9-0.29Bearish
  5. ROC 14-3.14Bearish
  6. ROC 25-10.55Bearish
  7. Stoch K31.90Neutral
  8. Stoch D23.89Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper37.39Neutral
  3. BB Middle34.71Neutral
  4. BB Lower32.04Neutral
  5. ATR0.76Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI36.94Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1034.70Bearish
  3. SMA 2035.72Bearish
  4. SMA 5037.63Bearish
  5. SMA 10037.04Bearish
  6. SMA 20042.87Bearish
  7. EMA 1034.45Bearish
  8. EMA 2035.37Bearish
  9. EMA 5036.54Bearish
  10. EMA 10038.31Bearish
  11. EMA 20042.65Bearish
  12. DEMA 1033.33Bullish
  13. DEMA 2034.07Bearish
  14. DEMA 5035.10Bearish
  15. DEMA 10034.29Bearish
  16. DEMA 200N/AN/A
  17. TEMA 1032.99Bullish
  18. TEMA 2033.39Bullish
  19. TEMA 5035.23Bearish
  20. TEMA 10034.95Bearish
  21. TEMA 200N/AN/A
  22. MACD-1.04Bearish
  23. ADX10.59Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI44.16Neutral
  3. CCI-107.99Oversold
  4. ROC 14-4.51Bearish
  5. ROC 25-10.79Bearish
  6. Stoch K10.17Oversold
  7. Stoch D4.58Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper39.33Neutral
  3. BB Middle35.72Neutral
  4. BB Lower32.11Neutral
  5. ATR1.49Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI41.58Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2036.19Bearish
  3. SMA 5040.14Bearish
  4. EMA 2036.76Bearish
  5. EMA 5040.21Bearish
  6. DEMA 2035.04Bearish
  7. DEMA 5034.16Bearish
  8. TEMA 2035.54Bearish
  9. TEMA 50N/AN/A
  10. MACD-1.25Bearish
  11. ADX35.17Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI43.46Neutral
  3. CCI-90.50Neutral
  4. ROC 14-15.34Bearish
  5. ROC 25-11.39Bearish
  6. Stoch K6.79Oversold
  7. Stoch D15.04Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper42.82Neutral
  3. BB Middle36.19Neutral
  4. BB Lower29.55Neutral
  5. ATR3.99Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI32.64Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 635.80Bearish
  3. SMA 1239.46Bearish
  4. SMA 2445.28Bearish
  5. EMA 636.80Bearish
  6. EMA 1239.55Bearish
  7. EMA 2445.27Bearish
  8. DEMA 634.80Bullish
  9. DEMA 1234.27Bullish
  10. DEMA 24N/AN/A
  11. TEMA 635.25Bearish
  12. TEMA 12N/AN/A
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADX17.66Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI37.13Neutral
  3. CCIN/AN/A
  4. ROC 25-44.17Bearish
  5. ROC 50N/AN/A
  6. Stoch KN/AN/A
  7. Stoch DN/AN/A
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper55.97Neutral
  3. BB Middle43.41Neutral
  4. BB Lower30.85Neutral
  5. ATR9.97Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI62.32Neutral